|
FREE Newsletter Timely Market Commentary Daily Stock Picks News Analysis |
|
Archive for the ‘Press Release’ Category
RockBrook Gears Up to Commercialize the Cannabis Science Brand of Pharmaceutical Products as It Airs One of the First Paid TV Ads on FOX Affiliate KTXL
COLORADO SPRINGS, Colo., Sept. 9, 2010 (CRWENEWSWIRE) — Cannabis Science, Inc. (OTCBB:CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased with its progress with RockBrook Inc. as its first commercialization license for the Cannabis Science Brand of Pharmaceutical Products for the State of Colorado. The licensing agreement grants RockBrook the full latitude and rights to manufacture, develop, produce, distribute, and sell products developed from, or based on Cannabis Science formulations, and delivery systems for the Cannabis Science Brand of Pharmaceutical Products and Cannabis Science Ailment Formulations within the State of Colorado.
On August 30, 2010, FOX affiliate KTXL (”FOX40″) aired one of the first paid U.S. television ads for a Cannabis Dispensary called CannaCare on its FOX40 Live morning news program. The 30-second ad focused on cannabis relief (treatment) for various medical ailments using true-life patient testimonials. Similarly, Cannabis Science is acquiring public testimonials using data acquired from RockBrook patients who use Cannabis Science Brands to evaluate our medical marijuana products prior to FDA clinical trials.
See: http://abcnews.go.com/Business/medical-marijuana-commercial-airs-california/story?id=11547326
“It is a matter of record within the medical community that medical marijuana can have positive results in helping relieve nausea and vomiting among cancer patients receiving chemotherapy and increasing appetites among AIDS patients,” Mike Armstrong, acting general manager of KTXL in Sacramento, said in a statement e-mailed to FOX40.com, alluding that the ad is no different from that of any medicine advertised by pharmaceutical companies on local television channels and cable networks for decades.
See: http://www.fox40.com/news/headlines/ktxl-news-potad0830,0,5605124.story
Cannabis Science President and CEO Dr. Robert Melamede, PhD., noted, “The FOX40 ad sets a new milestone for general public acceptance of medical cannabis. Centuries of knowledge record that cannabis is an efficacious medicinal treatment for a host of ailments, yet governments continues to cling to clouded ideologies against this natural medicine and instead support man-made pharmaceuticals that often produce more harm than medicinal good. We are optimistic that the unique holistic value of medical cannabis, with its ability to supplement our natural endocannabinoid system will continue to spread throughout the country and the world. Dispensaries currently lead the way throughout California and other U.S. states, such as Colorado where our licensed dispensary is located. The Company sees this as an opportune time to expand the marketing of its products and licensing dispensaries. We look forward to future TV marketing campaigns for Cannabis Science products and our licensed RockBrook dispensary.”
Richard Cowan, Cannabis Science CFO, added, “We are encouraged that mainstream media is accepting medical cannabis dispensary advertisements in California, which is opening the door for us to expand the advertisement of our own licensed dispensary and products. On August 30, 2010, FOX affiliate KTXL (”FOX40″) aired the first ever-paid U.S. television ad for a medical cannabis dispensary on its FOX40 Live morning news program. The 30-second ad focused on cannabis relief (treatment) for various medical ailments using true-life patient testimonials. From a marketing perspective, this is a huge leap forward in giving medical cannabis dispensaries the opportunities that chemically manufactured medicines have long held.”
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Forward Looking Statements; This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “plan,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
Contact:
Cannabis Science, Inc.
Dr. Robert J. Melamede, President & CEO
1-888-889-0888
Investor Relations
Mark J. Friedman
1-877-431-CBIS (2247)
info@cannabisscience.com
www.cannabisscience.com
********************************************************************
CRWEnewswire is not liable for the contents of this news, as well as not being liable for any errors or delays in the content, or for any actions taken in reliance thereon.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwenewswire.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars from a third party (VNC Associates LLC) for one (1) day of advertising for CANNABIS SCIENCE INC (OTC BB: CBIS.OB)
(BIIB, AAPL, CA) by CRWEWallstreet.com
Biogen Idec Inc. (NASDAQ: BIIB) advanced by 1.80%, closed at $57.15 while total traded volume was 2.20 million shares and the 50 days average price stood at $54.16. Biogen Idec Inc. (Biogen Idec) is a global biotechnology company. The products of the Company include AVONEX, RITUXAN, TYSABRI and FUMADERM. The Company’s products address diseases, such as multiple sclerosis (MS), non-Hodgkin’s lymphoma (NHL), rheumatoid arthritis (RA), Crohn’s disease (CD) and psoriasis. In addition to the marketed products, Biogen Idec has a number of product candidates in or near registrational stage development.
Apple Inc. (NASDAQ: AAPL) gained by 0.37%, closed at $257.81 while overall traded volume was 12.24 million shares and the 50 days average price stood at $253.74. Apple Inc. (Apple) designs, manufactures, and markets personal computers, mobile communication devices, and portable digital music and video players, and sells a variety of related software, services, peripherals, and networking solutions. The Company sells its products worldwide through its online stores, its retail stores, its direct sales force, and third-party wholesalers, resellers, and value-added resellers. In addition, the Company sells a variety of third-party Macintosh (Mac), iPhone and iPod compatible products, including application software, printers, storage devices, speakers, headphones, and various other accessories and peripherals through its online and retail stores, and digital content and applications through the iTunes Store.
CA, Inc. (NASDAQ: CA) reported the gain of 1.31%, closed at $19.30 with the traded volume of 5.80 million shares and the 50 days average price stood at $18.91. CA, Inc. (CA) is an independent enterprise information technology (IT) software and service company with capabilities across IT environments from mainframe and physical to virtual and cloud. CA develops and delivers software and services that help organizations to manage and secure their IT infrastructures and deliver flexible IT services. CA addresses most of the components of the computing environment, including people, information, processes, systems, networks, applications and databases, regardless of the hardware or software customers are using.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.(Read more at http://crwewallstreet.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
(NVE, EW, BUCY) by CRWEWallstreet.com
NV Energy, Inc. (NYSE: NVE) declined by 1.37%, closed at $12.95 while total traded volume was 1.84 million shares and the 50 days average price stood at $12.63. NV Energy, Inc. is an investor-owned holding company. The Company has six primary, wholly owned subsidiaries: Nevada Power Company (operating as NV Energy), Sierra Pacific Power Company (operating as NV Energy), Sierra Pacific Communications, Sierra Pacific Energy Company, NVE Insurance Company, Inc. and Lands of Sierra. NPC and SPPC are referred to collectively as the Utilities. The Utilities operate three business segments: NPC electric, SPPC electric and SPPC natural gas.
Edwards Lifesciences Corp (NYSE: EW) reported the loss of 1.58%, closed at $59.99 while overall traded volume was 1.02 million shares and the 50 days average price stood at $57.00. Edwards Lifesciences Corporation (Edwards Lifesciences) is a global player in products and technologies designed to treat advanced cardiovascular disease. The Company is focused specifically on technologies that treat structural heart disease and critically ill patients. The products and technologies provided by Edwards Lifesciences to treat advanced cardiovascular disease are categorized into four main areas: Heart Valve Therapy, Critical Care, Cardiac Surgery Systems and Vascular.
Bucyrus International, Inc. (NASDAQ: BUCY) advanced by 4.50%, closed at $67.11 with the traded volume of 3.98 million shares and the 50 days average price stood at $57.29. Bucyrus International, Inc. (Bucyrus) is a designer and manufacturer of safe and mining equipment for the extraction of coal, copper, oil sands, iron ore and other minerals in mining centers throughout the world. In addition to the manufacture of original equipment, Bucyrus also provides the aftermarket replacement parts and service for this equipment. Bucyrus operates in two business segments: surface mining, including the principal products of Terex Mining, and underground mining. All of its products and services are marketed under the Bucyrus name. The Company has manufacturing facilities in Australia, China, the Czech Republic, Germany, Mexico, the United Kingdom and the United States, and service and sales centers in Australia, Brazil, Canada, Chile, China, England, India, Indonesia, Mexico, Peru, Russia, South Africa and the United States.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.(Read more at http://crwewallstreet.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
EQ Labs Inks Agreement for Large Purchase Order to Place EQ Energy Drink in Major Convenience Store Chain
LAS VEGAS, Sept. 9, 2010 (CRWENEWSWIRE) — EQ Labs, Inc. (EQLB.PK) announced today that it closed a deal with Terrible Herbst Corporation to place EQ Energy Drink in 108 Terrible Herbst convenience stores effective immediately. As a result of this closing, EQ Labs expects to receive a large commercial order for its energy drink to stock all 108 Terrible Herbst stores within the next 30 days.
Terrible Herbst Corporation owns and operates gas stations and convenience stores in Nevada, California, Utah and Arizona. It also engages in operating car wash facilities, casinos, hotels, parks, slot routes, and motor sports, as well as in car lube and detail operations. The company was founded in 1937 and is based in Las Vegas, Nevada.
Many of the Terrible Herbst convenience stores are located in Chevron gas stations with point of purchase advertising displays. As a result of the closing of this deal with Terrible Herbst, EQ Labs will also receive point of purchase advertising at over 100 stores.
Mo Owens, Chief Executive Officer of EQ Labs, stated, “This order is confirmation of the popularity of EQ. We have spent a lot of time and energy building our brand. This order provides the economic benefit of a large order. In addition, the advertising opportunity and the desired location of many of Terrible Herbst’s locations will place our product line in front of millions of potential customers. “
Owens added, “This deal would not be possible without the help of Mark Walters and Rio Valentino. Mark Walters, Director of Merchandising and Sales for Terrible Herbst is an expert in the sales and merchandising business. We are also consummating a relationship with a major distributor as a result of Mark’s extensive relationships. I also can’t forget Rio Valentino, our Vice President of Sales. Rio’s persistence and skills is one of the biggest reasons why are sales are beginning to accelerate and we hope to make many more announcements like this one over the near future. This is a very big moment for our company.”
About EQ Labs, Inc. EQ Labs is engaged in the development, marketing and sale of EQ (”The Smart Energy Drink”). EQ is an effervescent tablet that can be dissolved in any beverage to provide instant energy. Consisting of a blend of essential vitamins, Gingko Biloba, and less caffeine than a cup of coffee. EQ is currently sold at Best Buy, 7-Eleven, Walgreens and other leading retailers. For more information about EQ, visit: http://www.drinkeq.com/.
Forward-Looking Statements: This press release contains forward-looking statements that reflect the Company’s current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by EQ Labs, Inc. are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance, or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Contact:
EQ Labs, Inc.
Maurice “Mo” Owens, CEO
702-445-7762
Fax: 702-445-7762
mo@drinkeq.com
Bob Fain, COO
bob@drinkeq.com
********************************************************************
CRWEnewswire is not liable for the contents of this news, as well as not being liable for any errors or delays in the content, or for any actions taken in reliance thereon.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwenewswire.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received fifteen thousand dollars in cash from a third party (EEA, Inc) for (7) days of advertising for EQ Labs, Inc. (EQLB.PK)
Two Bomb Low Intensity Blast Rock Lahore
Reported By: Anza CRWE Newswire Middle East correspondent
Two low intensity devices went off in Lahore, one outside a police officer’s house and the other along the boundary wall of the bomb disposal squad’s office. No casualty except a partially damaged police vehicle was reported.
Eye witnessed said that suspects riding motorcycles threw the bombs which exploded with a loud bang. Police and bomb disposal squads rushed to the spot, after being informed and collected evidence from the crime scene
Police believed that these explosions were used to create panic and also to shatter the confidence of the law enforcers during their war against terrorism in Pakistan, especially in Lahore.
Operations Deputy Inspector General, Rao Sardar, said that both blasts were of low intensity and the bombs were thrown from the motorcycles alongside the roads. He said a thorough search operation of the locality is being conducted and the culprits will be soon behind bars.
********************************************************************
The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.
